Filana Therapeutics, Inc.
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | – | 0.01 | 0.01 | 0.01 | – | |
| – | – | – | – | – | -0.01 | -0.01 | -0.01 | – | |
| 0.37 | 0.00 | 0.28 | 0.11 | 0.08 | 0.08 | 0.09 | 0.07 | 0.32 | |
| 0.27 | 0.00 | 0.23 | 0.83 | 0.16 | 0.20 | 0.14 | 0.13 | 0.63 | |
| 0.64 | 0.01 | 0.51 | 0.94 | 0.25 | 0.27 | 0.23 | 0.19 | 0.93 | |
| -0.64 | -0.01 | -0.51 | -0.94 | -0.25 | -0.28 | -0.23 | -0.19 | -0.95 | |
| -0.58 | -0.01 | -0.48 | -0.92 | -0.22 | -0.26 | -0.21 | -0.18 | -0.88 | |
| -0.58 | -0.01 | -0.48 | -0.92 | -0.22 | -0.26 | -0.21 | -0.18 | -0.88 | |
| -0.58 | -0.01 | -0.48 | -0.91 | -0.22 | -0.25 | -0.21 | -0.19 | -0.87 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.